METAXALONE

METAXALONE was reported 3352 times

METAXALONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PURPURA SENILE 12 0.0984
1 TARSAL TUNNEL SYNDROME 11 0.0500
2 PSYCHOGENIC PAIN DISORDER 3 0.0291
3 PSEUDODEMENTIA 3 0.0252
4 CEREBROVASCULAR SPASM 2 0.0152
5 ACCIDENTAL DEATH 26 0.0140
6 RESORPTION BONE INCREASED 11 0.0134
7 POST CONCUSSION SYNDROME 4 0.0118
8 MYOFASCIAL PAIN SYNDROME 8 0.0113
9 SECONDARY HYPERTENSION 3 0.0105
10 CEREBRAL VASOCONSTRICTION 7 0.0095
11 AUTOINFLAMMATORY DISEASE 2 0.0094
12 VESTIBULAR DISORDER 11 0.0090
13 SPINAL NERVE STIMULATOR IMPLANTATION 3 0.0088
14 CONGENITAL RENAL DISORDER 2 0.0075
15 CLONUS 20 0.0073
16 RAPID EYE MOVEMENTS SLEEP ABNORMAL 3 0.0071
17 VASCULITIS CEREBRAL 3 0.0067
18 BUTTOCK INJURY 2 0.0066
19 VERTIGO POSITIONAL 11 0.0063
20 BLOOD TRIGLYCERIDES DECREASED 2 0.0059
21 POSTURING 3 0.0058
22 ANOXIA 2 0.0057
23 PRE-EXISTING CONDITION IMPROVED 34 0.0054
24 OCCIPITAL NEURALGIA 3 0.0053
25 NEPHROGENIC ANAEMIA 24 0.0052
26 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2 0.0048
27 SPIDER VEIN 3 0.0047
28 HYPERREFLEXIA 16 0.0046
29 HYPERPARATHYROIDISM SECONDARY 11 0.0044
30 CATAPLEXY 6 0.0042
31 PARASOMNIA 3 0.0042
32 COMPLEX REGIONAL PAIN SYNDROME 6 0.0041
33 BLOOD CHLORIDE DECREASED 10 0.0039
34 CYST REMOVAL 2 0.0038
35 THROMBOPHLEBITIS SUPERFICIAL 11 0.0036
36 ESSENTIAL TREMOR 4 0.0036
37 MEDICATION OVERUSE HEADACHE 3 0.0035
38 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
39 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
40 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
41 REBOUND ACID HYPERSECRETION 10 0.0033
42 ABULIA 3 0.0032
43 EXPOSURE VIA INGESTION 8 0.0032
44 COMPLETED SUICIDE 261 0.0031
45 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
46 PROSTATE INFECTION 3 0.0031
47 ATROPHY 6 0.0031
48 SEROTONIN SYNDROME 59 0.0031
49 AUTONOMIC NEUROPATHY 3 0.0030
50 CEREBRAL CYST 2 0.0029
51 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
52 SOMATIC SYMPTOM DISORDER 3 0.0028
53 DRY AGE-RELATED MACULAR DEGENERATION 3 0.0027
54 CORNEAL DEPOSITS 2 0.0027
55 NEPHROGENIC DIABETES INSIPIDUS 3 0.0026
56 RECTAL PROLAPSE 3 0.0025
57 COSTOCHONDRITIS 4 0.0025
58 TOOTH EROSION 3 0.0024
59 ANXIETY DISORDER 8 0.0024
60 HEPATORENAL SYNDROME 4 0.0024
61 SUSPECTED SUICIDE 11 0.0023
62 CEREBELLAR ATROPHY 2 0.0023
63 ESSENTIAL HYPERTENSION 4 0.0022
64 SUICIDAL BEHAVIOUR 9 0.0022
65 INCISIONAL HERNIA 3 0.0022
66 CATHETER SITE SWELLING 2 0.0021
67 CHRONIC SINUSITIS 8 0.0021
68 BLOOD UREA ABNORMAL 2 0.0021
69 NARCOLEPSY 4 0.0021
70 DELAYED RECOVERY FROM ANAESTHESIA 2 0.0021
71 SCOLIOSIS 13 0.0021
72 ANTINUCLEAR ANTIBODY INCREASED 2 0.0021
73 BRONCHITIS CHRONIC 5 0.0020
74 SLEEP PARALYSIS 3 0.0020
75 END STAGE RENAL DISEASE 36 0.0020
76 CARPAL TUNNEL DECOMPRESSION 2 0.0019
77 EYE CONTUSION 4 0.0019
78 MULTIPLE DRUG OVERDOSE INTENTIONAL 6 0.0019
79 MUSCLE RIGIDITY 22 0.0018
80 CLAUSTROPHOBIA 2 0.0018
81 POISONING 23 0.0018
82 OXYGEN THERAPY 3 0.0018
83 PHLEBITIS 9 0.0018
84 BLOOD CHLORIDE INCREASED 3 0.0017
85 PATELLA FRACTURE 4 0.0017
86 ALLODYNIA 2 0.0017
87 INFUSION SITE DISCHARGE 3 0.0017
88 DEVICE INFUSION ISSUE 4 0.0016
89 CATHETER SITE HAEMORRHAGE 4 0.0016
90 EXCORIATION 4 0.0016
91 DRUG TITRATION ERROR 4 0.0015
92 CATHETER SITE PAIN 4 0.0015
93 BREAST ENLARGEMENT 5 0.0015
94 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
95 TEMPOROMANDIBULAR JOINT SYNDROME 4 0.0015
96 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
97 POTENTIATING DRUG INTERACTION 5 0.0015
98 CARBON DIOXIDE INCREASED 2 0.0015
99 OSTEOLYSIS 3 0.0015
100 CHRONIC KIDNEY DISEASE 111 0.0015
101 CORNEAL ABRASION 2 0.0015
102 SPINAL STENOSIS 6 0.0015
103 CHEST INJURY 3 0.0014
104 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 3 0.0014
105 CYSTIC FIBROSIS 8 0.0014
106 HYPERTHERMIA 11 0.0014
107 LUNG CONSOLIDATION 4 0.0014
108 CULTURE URINE POSITIVE 2 0.0014
109 SLEEP APNOEA SYNDROME 27 0.0014
110 MULTIPLE DRUG OVERDOSE 7 0.0014
111 MACULOPATHY 5 0.0014
112 CATHETER SITE ERYTHEMA 3 0.0014
113 INFUSION SITE BRUISING 3 0.0014
114 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 7 0.0014
115 TONGUE BLISTERING 3 0.0013
116 ASTIGMATISM 2 0.0013
117 FIBROMYALGIA 32 0.0013
118 CLAVICLE FRACTURE 5 0.0013
119 THYROID MASS 5 0.0013
120 DIASTOLIC DYSFUNCTION 4 0.0013
121 NECK SURGERY 3 0.0013
122 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 7 0.0013
123 ORAL SURGERY 3 0.0013
124 BLOOD PROLACTIN INCREASED 6 0.0013
125 HAND FRACTURE 9 0.0013
126 RESPIRATORY ARREST 35 0.0013
127 GLOMERULONEPHRITIS 3 0.0012
128 PERIPHERAL VENOUS DISEASE 5 0.0012
129 RESPIRATORY DEPRESSION 15 0.0012
130 INFUSION SITE HAEMORRHAGE 4 0.0012
131 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
132 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
133 LYME DISEASE 4 0.0012
134 NERVE COMPRESSION 11 0.0012
135 DERMATOMYOSITIS 3 0.0012
136 APPENDICITIS PERFORATED 3 0.0012
137 DRUG TOXICITY 16 0.0012
138 IMPAIRED GASTRIC EMPTYING 16 0.0012
139 LACTOSE INTOLERANCE 3 0.0012
140 MYDRIASIS 15 0.0012
141 MULTIPLE ALLERGIES 9 0.0011
142 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
143 SPINAL OPERATION 14 0.0011
144 ANIMAL BITE 3 0.0011
145 BLOOD SODIUM INCREASED 3 0.0011
146 CARDIO-RESPIRATORY ARREST 46 0.0011
147 TENOSYNOVITIS 3 0.0011
148 BLOOD IRON INCREASED 2 0.0011
149 PROTEIN TOTAL DECREASED 4 0.0011
150 WALKING AID USER 7 0.0011
151 SNORING 4 0.0011
152 BLOOD BICARBONATE DECREASED 2 0.0011
153 OSTEOPENIA 16 0.0011
154 VASCULITIS 12 0.0010
155 ALCOHOL INTERACTION 2 0.0010
156 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
157 NECK INJURY 3 0.0010
158 JOINT EFFUSION 7 0.0010
159 ANORECTAL DISORDER 2 0.0010
160 ENURESIS 4 0.0010
161 BURSITIS 12 0.0010
162 DRUG TOLERANCE 5 0.0010
163 SPINAL FUSION SURGERY 4 0.0010
164 TRIGGER FINGER 4 0.0010
165 CHANGE OF BOWEL HABIT 2 0.0010
166 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
167 TOXICITY TO VARIOUS AGENTS 164 0.0010
168 BODY TEMPERATURE FLUCTUATION 2 0.0010
169 MALABSORPTION 5 0.0010
170 BLOOD SODIUM DECREASED 18 0.0010
171 FOREIGN BODY IN THROAT 3 0.0010
172 INFUSION SITE PRURITUS 3 0.0009
173 DRUG EFFECT INCREASED 3 0.0009
174 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
175 ARTHROPOD BITE 7 0.0009
176 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
177 UTERINE HAEMORRHAGE 4 0.0009
178 BLOOD TESTOSTERONE INCREASED 2 0.0009
179 VITAMIN D DEFICIENCY 9 0.0009
180 BACK INJURY 10 0.0009
181 DIVERTICULUM INTESTINAL 4 0.0009
182 TONGUE DISCOLOURATION 4 0.0009
183 BIPOLAR I DISORDER 2 0.0009
184 SPINAL OSTEOARTHRITIS 8 0.0009
185 DISABILITY 18 0.0009
186 COLONOSCOPY 2 0.0009
187 LIGAMENT RUPTURE 4 0.0009
188 HYPOTONIA 9 0.0009
189 PRODUCT LEAKAGE 5 0.0009
190 SUBARACHNOID HAEMORRHAGE 9 0.0009
191 VASCULAR DEVICE INFECTION 4 0.0009
192 TEMPERATURE INTOLERANCE 9 0.0009
193 BRAIN OEDEMA 11 0.0009
194 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
195 BREAKTHROUGH PAIN 2 0.0009
196 HYPERVENTILATION 5 0.0009
197 AORTIC STENOSIS 3 0.0009
198 SPINAL COLUMN STENOSIS 4 0.0008
199 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
200 FOOT FRACTURE 16 0.0008
201 ENDOMETRIOSIS 4 0.0008
202 INFUSION SITE ERYTHEMA 7 0.0008
203 MAJOR DEPRESSION 6 0.0008
204 NO THERAPEUTIC RESPONSE 10 0.0008
205 VITAMIN D DECREASED 7 0.0008
206 RENAL TUBULAR NECROSIS 8 0.0008
207 ALCOHOL USE 3 0.0008
208 CARTILAGE INJURY 2 0.0008
209 NERVE INJURY 9 0.0008
210 RENAL FAILURE 107 0.0008
211 MUSCLE TIGHTNESS 13 0.0008
212 OSTEOPOROSIS 33 0.0008
213 INFUSION SITE SWELLING 5 0.0008
214 FACE INJURY 3 0.0008
215 CARPAL TUNNEL SYNDROME 11 0.0008
216 ROTATOR CUFF SYNDROME 10 0.0008
217 OSTEOARTHRITIS 33 0.0008
218 CONCUSSION 6 0.0008
219 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
220 EXOSTOSIS 7 0.0008
221 SCIATICA 12 0.0008
222 WRIST FRACTURE 9 0.0008
223 AREFLEXIA 2 0.0007
224 BODY HEIGHT DECREASED 8 0.0007
225 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
226 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
227 IRRITABLE BOWEL SYNDROME 16 0.0007
228 POST-TRAUMATIC STRESS DISORDER 5 0.0007
229 POSTOPERATIVE WOUND INFECTION 5 0.0007
230 HIP SURGERY 4 0.0007
231 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
232 GLAUCOMA 14 0.0007
233 LYMPHOEDEMA 5 0.0007
234 HAIR GROWTH ABNORMAL 5 0.0007
235 CONGESTIVE CARDIOMYOPATHY 3 0.0007
236 SLEEP TERROR 3 0.0007
237 ANKLE FRACTURE 11 0.0007
238 TENDONITIS 11 0.0007
239 STATUS EPILEPTICUS 8 0.0007
240 LIGAMENT SPRAIN 7 0.0007
241 THERMAL BURN 5 0.0007
242 DRUG ABUSE 58 0.0007
243 HIATUS HERNIA 9 0.0007
244 MUSCLE TWITCHING 16 0.0007
245 HEPATIC LESION 3 0.0007
246 MUSCLE STRAIN 6 0.0007
247 BRONCHITIS 51 0.0007
248 MENTAL STATUS CHANGES 19 0.0007
249 HAEMORRHAGIC ANAEMIA 3 0.0007
250 INITIAL INSOMNIA 7 0.0007
251 URINE ODOUR ABNORMAL 4 0.0007
252 PHYSICAL DISABILITY 3 0.0007
253 DECREASED INTEREST 4 0.0007
254 ENERGY INCREASED 4 0.0007
255 RHINITIS ALLERGIC 3 0.0007
256 SINUS HEADACHE 4 0.0007
257 CREPITATIONS 2 0.0007
258 INTENTIONAL DRUG MISUSE 14 0.0007
259 PROTHROMBIN TIME PROLONGED 4 0.0007
260 ATYPICAL PNEUMONIA 2 0.0007
261 BLOOD CULTURE POSITIVE 2 0.0007
262 ANAL INCONTINENCE 6 0.0007
263 URINARY TRACT DISORDER 3 0.0007
264 GASTROENTERITIS VIRAL 12 0.0007
265 INCONTINENCE 7 0.0007
266 CRANIOCEREBRAL INJURY 2 0.0007
267 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
268 TROPONIN INCREASED 5 0.0007
269 SINUSITIS 67 0.0007
270 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
271 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
272 BRAIN DEATH 2 0.0006
273 FEELING OF DESPAIR 3 0.0006
274 BLOOD BLISTER 2 0.0006
275 LACERATION 6 0.0006
276 SEASONAL ALLERGY 9 0.0006
277 ABDOMINAL ADHESIONS 2 0.0006
278 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
279 FAECAL INCONTINENCE 3 0.0006
280 INFUSION SITE PAIN 8 0.0006
281 MIGRAINE 59 0.0006
282 INCOHERENT 4 0.0006
283 MUSCLE DISORDER 5 0.0006
284 HAEMORRHOIDS 12 0.0006
285 KIDNEY INFECTION 12 0.0006
286 CHOLELITHIASIS 20 0.0006
287 SOMNAMBULISM 4 0.0006
288 COMA 29 0.0006
289 SPRUE-LIKE ENTEROPATHY 3 0.0006
290 PULMONARY CONGESTION 8 0.0006
291 MUCOUS STOOLS 3 0.0006
292 HAEMORRHAGE INTRACRANIAL 9 0.0006
293 EAR INFECTION 16 0.0006
294 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
295 GASTROOESOPHAGEAL REFLUX DISEASE 48 0.0006
296 ULCER HAEMORRHAGE 4 0.0006
297 RIB FRACTURE 12 0.0006
298 TRISMUS 3 0.0006
299 SURGERY 34 0.0006
300 FAILURE TO THRIVE 3 0.0006
301 LARGE INTESTINE POLYP 4 0.0006
302 HYSTERECTOMY 5 0.0006
303 TENDERNESS 6 0.0006
304 WEIGHT FLUCTUATION 6 0.0006
305 SENSITIVITY TO WEATHER CHANGE 3 0.0006
306 FOOD CRAVING 3 0.0006
307 JOINT DISLOCATION 6 0.0006
308 ANORECTAL DISCOMFORT 3 0.0006
309 DIVERTICULUM 4 0.0006
310 JOINT INJURY 12 0.0006
311 OVERWEIGHT 3 0.0006
312 STRESS FRACTURE 3 0.0006
313 ACUTE KIDNEY INJURY 85 0.0006
314 BLOOD POTASSIUM INCREASED 9 0.0006
315 PANIC REACTION 4 0.0006
316 BIPOLAR DISORDER 6 0.0006
317 PRESCRIBED UNDERDOSE 11 0.0006
318 LUPUS-LIKE SYNDROME 5 0.0006
319 INTENTIONAL UNDERDOSE 4 0.0005
320 INCREASED TENDENCY TO BRUISE 5 0.0005
321 DENTAL CARIES 6 0.0005
322 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
323 CARDIOMYOPATHY 8 0.0005
324 BLOOD UREA INCREASED 9 0.0005
325 SUNBURN 4 0.0005
326 NEURALGIA 13 0.0005
327 MUSCLE SPASMS 98 0.0005
328 BREAST TENDERNESS 4 0.0005
329 CATHETER SITE INFECTION 2 0.0005
330 ECONOMIC PROBLEM 8 0.0005
331 EXERCISE TOLERANCE DECREASED 3 0.0005
332 DELIRIUM 18 0.0005
333 ORTHOSTATIC HYPOTENSION 9 0.0005
334 PELVIC FRACTURE 4 0.0005
335 CHOKING 10 0.0005
336 SPINAL PAIN 6 0.0005
337 BRAIN FOG 8 0.0005
338 FUNGAL INFECTION 17 0.0005
339 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
340 CATARACT OPERATION 3 0.0005
341 PLEURISY 3 0.0005
342 DIVERTICULITIS 14 0.0005
343 RENAL INJURY 15 0.0005
344 UNRESPONSIVE TO STIMULI 13 0.0005
345 GOUT 9 0.0005
346 MASS 7 0.0005
347 MIOSIS 4 0.0005
348 CARDIAC ARREST 41 0.0005
349 RESTLESS LEGS SYNDROME 9 0.0005
350 NEUROPATHY PERIPHERAL 47 0.0005
351 BACK DISORDER 8 0.0005
352 DECUBITUS ULCER 4 0.0005
353 HYPERSOMNIA 14 0.0005
354 ABNORMAL FAECES 4 0.0005
355 MENISCUS INJURY 3 0.0005
356 CARDIOMEGALY 6 0.0005
357 SMALL INTESTINAL OBSTRUCTION 6 0.0005
358 EAR DISCOMFORT 5 0.0005
359 PIGMENTATION DISORDER 3 0.0005
360 TOOTH EXTRACTION 6 0.0005
361 INFUSION SITE EXTRAVASATION 3 0.0005
362 EYE DISCHARGE 5 0.0005
363 SECRETION DISCHARGE 6 0.0005
364 FALL 159 0.0005
365 MUSCULOSKELETAL DISORDER 9 0.0005
366 CYSTITIS 15 0.0005
367 SCREAMING 3 0.0005
368 ABSCESS LIMB 2 0.0005
369 PRODUCT SUBSTITUTION ISSUE 27 0.0005
370 HEREDITARY ANGIOEDEMA 5 0.0005
371 MEMORY IMPAIRMENT 63 0.0005
372 NEPHROLITHIASIS 21 0.0005
373 ARTHRITIS 36 0.0005
374 WOUND INFECTION 5 0.0005
375 TOOTH INFECTION 6 0.0005
376 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
377 GASTROINTESTINAL PAIN 5 0.0005
378 SARS-COV-2 TEST POSITIVE 6 0.0005
379 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
380 TOOTH DISORDER 10 0.0004
381 UNEVALUABLE EVENT 34 0.0004
382 ORAL PAIN 10 0.0004
383 GASTROINTESTINAL INFECTION 4 0.0004
384 ABASIA 11 0.0004
385 BLOOD CALCIUM DECREASED 5 0.0004
386 BACK PAIN 103 0.0004
387 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
388 HEAD INJURY 14 0.0004
389 MITRAL VALVE INCOMPETENCE 5 0.0004
390 ABNORMAL LOSS OF WEIGHT 3 0.0004
391 OBESITY 7 0.0004
392 BLOOD TESTOSTERONE DECREASED 3 0.0004
393 DERMATITIS CONTACT 5 0.0004
394 MICTURITION URGENCY 5 0.0004
395 INTERNAL HAEMORRHAGE 5 0.0004
396 ONYCHOCLASIS 3 0.0004
397 RESPIRATION ABNORMAL 3 0.0004
398 UROSEPSIS 4 0.0004
399 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
400 BLOOD POTASSIUM DECREASED 13 0.0004
401 ORAL DISCOMFORT 6 0.0004
402 ROAD TRAFFIC ACCIDENT 18 0.0004
403 NEPHROPATHY 4 0.0004
404 RIGHT VENTRICULAR FAILURE 3 0.0004
405 KNEE ARTHROPLASTY 9 0.0004
406 COVID-19 PNEUMONIA 5 0.0004
407 DRUG LEVEL INCREASED 7 0.0004
408 FRACTURE 8 0.0004
409 SPINAL DISORDER 4 0.0004
410 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
411 CARDIAC TAMPONADE 2 0.0004
412 PSORIATIC ARTHROPATHY 17 0.0004
413 ANHEDONIA 11 0.0004
414 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
415 DEPRESSION 95 0.0004
416 DEEP VEIN THROMBOSIS 27 0.0004
417 CONTUSION 40 0.0004
418 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
419 LOCALISED INFECTION 10 0.0004
420 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
421 AUTOIMMUNE DISORDER 4 0.0004
422 ORAL DISORDER 3 0.0004
423 PHARYNGEAL SWELLING 4 0.0004
424 COELIAC DISEASE 4 0.0004
425 MENORRHAGIA 8 0.0004
426 THERAPY CHANGE 4 0.0004
427 MUSCULOSKELETAL DISCOMFORT 7 0.0004
428 KNEE OPERATION 4 0.0004
429 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
430 HYPERCALCAEMIA 5 0.0004
431 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
432 SINUS DISORDER 8 0.0004
433 HYPOAESTHESIA ORAL 6 0.0004
434 HEAD DISCOMFORT 7 0.0004
435 NECK PAIN 22 0.0004
436 INJECTION SITE IRRITATION 5 0.0004
437 BODY TEMPERATURE INCREASED 8 0.0004
438 THIRST 7 0.0004
439 BOWEL MOVEMENT IRREGULARITY 3 0.0004
440 INTENTIONAL OVERDOSE 25 0.0004
441 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
442 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
443 TOOTHACHE 7 0.0004
444 BONE DISORDER 7 0.0004
445 PLATELET COUNT INCREASED 5 0.0004
446 HYPERTENSION 81 0.0004
447 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
448 AFFECTIVE DISORDER 3 0.0004
449 GASTRITIS 10 0.0004
450 DRUG SCREEN POSITIVE 3 0.0004
451 MULTIPLE SCLEROSIS RELAPSE 26 0.0004
452 PNEUMOTHORAX 6 0.0004
453 BLOOD ALBUMIN DECREASED 3 0.0004
454 RENAL PAIN 4 0.0004
455 GINGIVAL PAIN 3 0.0004
456 HYPOTHYROIDISM 12 0.0004
457 METABOLIC ACIDOSIS 12 0.0004
458 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
459 HAIR TEXTURE ABNORMAL 5 0.0004
460 QUALITY OF LIFE DECREASED 5 0.0004
461 PHOTOPHOBIA 7 0.0004
462 DRUG INTERACTION 59 0.0004
463 POOR QUALITY SLEEP 8 0.0004
464 MYASTHENIA GRAVIS 3 0.0004
465 MENTAL IMPAIRMENT 9 0.0004
466 ANAL ABSCESS 2 0.0004
467 SINUS CONGESTION 5 0.0004
468 DYSKINESIA 15 0.0004
469 POST PROCEDURAL INFECTION 3 0.0004
470 SUBSTANCE ABUSE 3 0.0004
471 LIMB INJURY 10 0.0004
472 SKIN LACERATION 4 0.0004
473 MULTIPLE FRACTURES 6 0.0004
474 ESCHERICHIA INFECTION 3 0.0004
475 LOWER LIMB FRACTURE 7 0.0004
476 HAIR DISORDER 3 0.0004
477 STAPHYLOCOCCAL INFECTION 12 0.0004
478 PHOTOSENSITIVITY REACTION 6 0.0004
479 FOOT DEFORMITY 4 0.0004
480 DRY EYE 18 0.0004
481 PROCEDURAL PAIN 10 0.0004
482 THROMBOSIS 29 0.0004
483 LIP SWELLING 12 0.0004
484 STEVENS-JOHNSON SYNDROME 8 0.0004
485 BALANCE DISORDER 31 0.0004
486 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
487 CONSTIPATION 78 0.0004
488 SOMNOLENCE 72 0.0004
489 HAEMODIALYSIS 3 0.0004
490 FEELING ABNORMAL 85 0.0004
491 CHOLECYSTITIS ACUTE 2 0.0004
492 SINUS TACHYCARDIA 5 0.0004
493 IMPAIRED DRIVING ABILITY 4 0.0004
494 UPPER LIMB FRACTURE 7 0.0004
495 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
496 SCAR 6 0.0004
497 BRONCHOSPASM 5 0.0004
498 SPINAL FRACTURE 7 0.0003
499 BLOOD MAGNESIUM DECREASED 3 0.0003
500 CARDIAC MURMUR 3 0.0003
501 PYELONEPHRITIS 3 0.0003
502 RESPIRATORY TRACT INFECTION 9 0.0003
503 MUSCULOSKELETAL PAIN 18 0.0003
504 BLOOD CHOLESTEROL INCREASED 16 0.0003
505 JOINT STIFFNESS 9 0.0003
506 PAIN IN EXTREMITY 101 0.0003
507 MOVEMENT DISORDER 11 0.0003
508 DYSSTASIA 10 0.0003
509 NIGHT SWEATS 11 0.0003
510 INFLUENZA 38 0.0003
511 COLD SWEAT 6 0.0003
512 AMNESIA 22 0.0003
513 ATAXIA 4 0.0003
514 ACCIDENT 4 0.0003
515 MYOSITIS 3 0.0003
516 FLUID RETENTION 17 0.0003
517 POLYNEUROPATHY 4 0.0003
518 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
519 BLOOD PRESSURE FLUCTUATION 8 0.0003
520 BONE LOSS 5 0.0003
521 OSTEOMYELITIS 6 0.0003
522 INSOMNIA 88 0.0003
523 ADRENAL INSUFFICIENCY 4 0.0003
524 INFLAMMATION 17 0.0003
525 PAIN 201 0.0003
526 INSURANCE ISSUE 5 0.0003
527 TINNITUS 15 0.0003
528 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
529 SLEEP DISORDER 23 0.0003
530 IRON DEFICIENCY ANAEMIA 3 0.0003
531 PERIPHERAL SWELLING 50 0.0003
532 PRODUCT DISTRIBUTION ISSUE 3 0.0003
533 NASAL CONGESTION 19 0.0003
534 MUSCULOSKELETAL CHEST PAIN 5 0.0003
535 HEPATIC STEATOSIS 6 0.0003
536 APPLICATION SITE IRRITATION 4 0.0003
537 HAIR COLOUR CHANGES 4 0.0003
538 DIARRHOEA HAEMORRHAGIC 3 0.0003
539 PNEUMONIA ASPIRATION 8 0.0003
540 MOBILITY DECREASED 23 0.0003
541 FLANK PAIN 3 0.0003
542 BONE DENSITY DECREASED 10 0.0003
543 ULCER 5 0.0003
544 DRUG PRESCRIBING ERROR 6 0.0003
545 THROAT IRRITATION 14 0.0003
546 THERAPY NON-RESPONDER 14 0.0003
547 URINARY TRACT INFECTION 53 0.0003
548 HYPERCHOLESTEROLAEMIA 3 0.0003
549 ANOREXIA 4 0.0003
550 ABDOMINAL DISCOMFORT 52 0.0003
551 DIZZINESS POSTURAL 3 0.0003
552 HAEMATOMA 8 0.0003
553 EAR PAIN 6 0.0003
554 PARKINSONISM 3 0.0003
555 SKIN FISSURES 6 0.0003
556 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
557 NODULE 4 0.0003
558 BRADYPHRENIA 2 0.0003
559 ASPERGILLUS INFECTION 2 0.0003
560 SKIN DISCOLOURATION 14 0.0003
561 TACHYCARDIA 27 0.0003
562 URINARY INCONTINENCE 9 0.0003
563 IMMUNE SYSTEM DISORDER 4 0.0003
564 ANKYLOSING SPONDYLITIS 4 0.0003
565 HYPERHIDROSIS 39 0.0003
566 BLADDER DISORDER 3 0.0003
567 BLOOD PRESSURE ABNORMAL 6 0.0003
568 DIABETES MELLITUS 23 0.0003
569 OVERDOSE 65 0.0003
570 WEIGHT DECREASED 84 0.0003
571 CARDIAC FAILURE ACUTE 2 0.0003
572 OVARIAN CYST 3 0.0003
573 AGITATION 22 0.0003
574 RHEUMATOID ARTHRITIS 34 0.0003
575 CHOLECYSTITIS CHRONIC 2 0.0003
576 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
577 EYELID PTOSIS 3 0.0003
578 GINGIVAL BLEEDING 4 0.0003
579 GAIT DISTURBANCE 56 0.0003
580 THERAPY CESSATION 15 0.0003
581 CORONARY ARTERY OCCLUSION 4 0.0003
582 ANXIETY 83 0.0003
583 PERIPHERAL COLDNESS 4 0.0003
584 LIMB DISCOMFORT 9 0.0003
585 VENTRICULAR EXTRASYSTOLES 3 0.0003
586 PULMONARY HYPERTENSION 6 0.0003
587 COORDINATION ABNORMAL 4 0.0003
588 APHONIA 4 0.0003
589 TRANSFUSION 3 0.0003
590 RASH MACULAR 10 0.0003
591 CATARACT 17 0.0003
592 DYSPEPSIA 28 0.0003
593 SUICIDAL IDEATION 26 0.0003
594 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
595 RETCHING 6 0.0003
596 BREAST PAIN 3 0.0003
597 INTENTIONAL DOSE OMISSION 8 0.0003
598 CEREBRAL HAEMORRHAGE 10 0.0003
599 VERTIGO 17 0.0003
600 DRUG EFFECT DECREASED 15 0.0003
601 DISTURBANCE IN ATTENTION 15 0.0003
602 DECREASED ACTIVITY 3 0.0003
603 PHARYNGITIS STREPTOCOCCAL 3 0.0003
604 BLOOD CREATININE INCREASED 18 0.0003
605 HYPOKINESIA 4 0.0003
606 FLUSHING 28 0.0003
607 FLUID OVERLOAD 4 0.0003
608 HEADACHE 172 0.0003
609 APATHY 4 0.0003
610 CARDIAC FAILURE CONGESTIVE 22 0.0003
611 TOOTH FRACTURE 3 0.0003
612 MULTIPLE SCLEROSIS 13 0.0003
613 DYSURIA 10 0.0003
614 DRY MOUTH 22 0.0003
615 VISUAL ACUITY REDUCED 9 0.0003
616 EXPIRED PRODUCT ADMINISTERED 9 0.0003
617 CEREBRAL DISORDER 2 0.0003
618 INJURY 19 0.0003
619 DIPLOPIA 7 0.0003
620 PULMONARY MASS 4 0.0003
621 SKIN INFECTION 3 0.0003
622 DYSPNOEA EXERTIONAL 10 0.0003
623 MUSCULAR WEAKNESS 30 0.0003
624 AORTIC ANEURYSM 2 0.0003
625 DEHYDRATION 35 0.0003
626 FEELING JITTERY 5 0.0003
627 BLOOD PRESSURE INCREASED 40 0.0003
628 HERPES ZOSTER 15 0.0003
629 FEELING HOT 16 0.0003
630 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
631 POST PROCEDURAL COMPLICATION 5 0.0003
632 FEAR 7 0.0003
633 HYPOKALAEMIA 12 0.0003
634 PERICARDIAL EFFUSION 6 0.0003
635 HERNIA 5 0.0003
636 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
637 RENAL DISORDER 12 0.0003
638 ASTHMA 29 0.0003
639 PNEUMONIA 83 0.0003
640 NERVOUS SYSTEM DISORDER 8 0.0003
641 RECTAL HAEMORRHAGE 11 0.0003
642 INFLUENZA LIKE ILLNESS 21 0.0003
643 FATIGUE 198 0.0003
644 ABNORMAL BEHAVIOUR 10 0.0003
645 DISORIENTATION 10 0.0003
646 HEART RATE INCREASED 25 0.0003
647 HAEMATOCRIT DECREASED 5 0.0003
648 MYOCLONUS 3 0.0003
649 NAUSEA 199 0.0003
650 MACULAR DEGENERATION 3 0.0003
651 MOOD SWINGS 8 0.0003
652 ATRIAL FLUTTER 2 0.0003
653 HEPATIC ENZYME INCREASED 17 0.0002
654 SENSORY DISTURBANCE 4 0.0002
655 NERVOUSNESS 13 0.0002
656 HIP FRACTURE 8 0.0002
657 HEPATITIS C 3 0.0002
658 FULL BLOOD COUNT DECREASED 5 0.0002
659 CRYING 9 0.0002
660 PALPITATIONS 29 0.0002
661 PRODUCT ADMINISTRATION ERROR 5 0.0002
662 DIZZINESS 123 0.0002
663 WEIGHT INCREASED 55 0.0002
664 HYPOTENSION 49 0.0002
665 IMPAIRED HEALING 8 0.0002
666 PRODUCT PREPARATION ERROR 5 0.0002
667 INJECTION SITE EXTRAVASATION 3 0.0002
668 TENDON RUPTURE 3 0.0002
669 ILLNESS 25 0.0002
670 HYPERSENSITIVITY 45 0.0002
671 ACUTE CORONARY SYNDROME 2 0.0002
672 ILEUS 3 0.0002
673 INFUSION RELATED REACTION 16 0.0002
674 TOOTH LOSS 5 0.0002
675 VOMITING 113 0.0002
676 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
677 MUSCULOSKELETAL STIFFNESS 21 0.0002
678 ALOPECIA 47 0.0002
679 HOT FLUSH 18 0.0002
680 OROPHARYNGEAL PAIN 22 0.0002
681 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
682 HALLUCINATION, VISUAL 5 0.0002
683 ATRIAL FIBRILLATION 23 0.0002
684 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
685 HYPOPHAGIA 6 0.0002
686 CARDIAC OPERATION 2 0.0002
687 RHINORRHOEA 15 0.0002
688 PARANOIA 4 0.0002
689 RASH GENERALISED 6 0.0002
690 ASTHENIA 87 0.0002
691 FAECES DISCOLOURED 5 0.0002
692 MYALGIA 39 0.0002
693 LOCAL SWELLING 4 0.0002
694 SEDATION 6 0.0002
695 BLOOD GLUCOSE DECREASED 11 0.0002
696 TREMOR 38 0.0002
697 BEDRIDDEN 3 0.0002
698 BURNING SENSATION 16 0.0002
699 NASOPHARYNGITIS 42 0.0002
700 HYPOXIA 8 0.0002
701 LYMPHADENOPATHY 8 0.0002
702 VISUAL IMPAIRMENT 28 0.0002
703 MALIGNANT MELANOMA 3 0.0002
704 JOINT RANGE OF MOTION DECREASED 3 0.0002
705 GASTROINTESTINAL DISORDER 20 0.0002
706 BLOOD BILIRUBIN INCREASED 6 0.0002
707 SYNOVITIS 4 0.0002
708 CHROMATURIA 5 0.0002
709 TACHYPNOEA 3 0.0002
710 DRUG EFFECT INCOMPLETE 8 0.0002
711 RESPIRATORY FAILURE 16 0.0002
712 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
713 LOSS OF CONSCIOUSNESS 28 0.0002
714 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
715 APPLICATION SITE RASH 3 0.0002
716 ABNORMAL DREAMS 6 0.0002
717 IRRITABILITY 13 0.0002
718 DYSPNOEA 122 0.0002
719 HUNGER 3 0.0002
720 THINKING ABNORMAL 4 0.0002
721 THERAPEUTIC RESPONSE DECREASED 13 0.0002
722 BACTERIAL INFECTION 4 0.0002
723 STOMATITIS 13 0.0002
724 MIDDLE INSOMNIA 4 0.0002
725 ARTHRALGIA 89 0.0002
726 DEFORMITY 2 0.0002
727 COUGH 60 0.0002
728 BLISTER 12 0.0002
729 RASH 93 0.0002
730 HEPATIC CIRRHOSIS 4 0.0002
731 ARTERIOSCLEROSIS 2 0.0002
732 RENAL FAILURE ACUTE 9 0.0002
733 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
734 PAIN IN JAW 6 0.0002
735 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
736 BLOOD URINE PRESENT 4 0.0002
737 THERAPY INTERRUPTED 15 0.0002
738 PRODUCTIVE COUGH 10 0.0002
739 GAIT INABILITY 7 0.0002
740 DIARRHOEA 135 0.0002
741 ABDOMINAL PAIN UPPER 43 0.0002
742 IMPAIRED QUALITY OF LIFE 3 0.0002
743 DEPRESSED MOOD 11 0.0002
744 PARAESTHESIA ORAL 3 0.0002
745 CONDITION AGGRAVATED 63 0.0002
746 HYPOAESTHESIA 31 0.0002
747 ATELECTASIS 2 0.0002
748 LIVER FUNCTION TEST ABNORMAL 6 0.0002
749 INTENTIONAL PRODUCT MISUSE 18 0.0002
750 DYSPHONIA 12 0.0002
751 OEDEMA PERIPHERAL 25 0.0002
752 PLASMA CELL MYELOMA 8 0.0002
753 CEREBRAL INFARCTION 5 0.0002
754 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
755 PSYCHOTIC DISORDER 6 0.0002
756 DYSGEUSIA 15 0.0002
757 IMMUNODEFICIENCY 3 0.0002
758 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
759 RESPIRATORY DISORDER 6 0.0002
760 PRURITUS 77 0.0002
761 SYNCOPE 20 0.0002
762 CHEST PAIN 37 0.0002
763 SWELLING FACE 13 0.0002
764 COVID-19 35 0.0002
765 APHASIA 6 0.0002
766 CELLULITIS 10 0.0002
767 EMOTIONAL DISTRESS 24 0.0002
768 CONFUSIONAL STATE 32 0.0002
769 BLOOD COUNT ABNORMAL 3 0.0002
770 FEEDING DISORDER 4 0.0002
771 HIP ARTHROPLASTY 3 0.0002
772 PHARYNGEAL OEDEMA 3 0.0002
773 EYE PAIN 11 0.0002
774 DEVICE RELATED INFECTION 3 0.0002
775 FLATULENCE 11 0.0002
776 PRODUCT DOSE OMISSION ISSUE 57 0.0002
777 ABDOMINAL PAIN 45 0.0002
778 SKIN ULCER 5 0.0002
779 THERAPY PARTIAL RESPONDER 3 0.0002
780 POLLAKIURIA 8 0.0002
781 MALAISE 84 0.0002
782 DEAFNESS 5 0.0002
783 SPEECH DISORDER 10 0.0002
784 WITHDRAWAL SYNDROME 8 0.0002
785 RENAL IMPAIRMENT 16 0.0002
786 MOUTH ULCERATION 4 0.0002
787 OCULAR HYPERAEMIA 9 0.0002
788 INJECTION SITE MASS 7 0.0002
789 ADVERSE DRUG REACTION 17 0.0002
790 INJECTION SITE REACTION 13 0.0002
791 RESPIRATORY TRACT CONGESTION 3 0.0002
792 EYE SWELLING 7 0.0002
793 BONE PAIN 11 0.0002
794 IMPAIRED WORK ABILITY 4 0.0002
795 INFECTION 27 0.0002
796 PAIN OF SKIN 5 0.0002
797 PRURITUS GENERALISED 4 0.0002
798 BLOOD GLUCOSE FLUCTUATION 2 0.0002
799 SKIN LESION 5 0.0002
800 SUICIDE ATTEMPT 11 0.0002
801 BLOOD PRESSURE DECREASED 12 0.0002
802 VIRAL INFECTION 6 0.0002
803 ARTHROPATHY 10 0.0002
804 HAEMOPTYSIS 5 0.0002
805 DYSPHAGIA 17 0.0002
806 URTICARIA 30 0.0002
807 COLITIS ULCERATIVE 8 0.0002
808 CANDIDA INFECTION 3 0.0002
809 HYPONATRAEMIA 10 0.0002
810 HEMIPARESIS 3 0.0002
811 CHEST DISCOMFORT 18 0.0002
812 DRUG DOSE OMISSION 29 0.0002
813 CHOLECYSTECTOMY 2 0.0002
814 RED BLOOD CELL COUNT DECREASED 5 0.0002
815 EPISTAXIS 13 0.0002
816 EYE IRRITATION 10 0.0002
817 NIGHTMARE 6 0.0002
818 HALLUCINATION 13 0.0002
819 SWELLING 16 0.0002
820 DRUG ERUPTION 3 0.0002
821 ARRHYTHMIA 8 0.0002
822 BLOOD IRON DECREASED 2 0.0002
823 GALLBLADDER DISORDER 3 0.0002
824 DECREASED APPETITE 39 0.0002
825 CHOLECYSTITIS 2 0.0002
826 RASH PRURITIC 9 0.0002
827 COMPLICATION OF DEVICE REMOVAL 3 0.0002
828 LACRIMATION INCREASED 5 0.0002
829 PARAESTHESIA 26 0.0002
830 CORONARY ARTERY DISEASE 5 0.0002
831 PANIC ATTACK 6 0.0002
832 ACCIDENTAL OVERDOSE 6 0.0002
833 RESTLESSNESS 6 0.0002
834 LUNG DISORDER 8 0.0002
835 INJECTION SITE URTICARIA 4 0.0002
836 MEDICATION ERROR 9 0.0002
837 FEMUR FRACTURE 5 0.0002
838 INJECTION SITE ERYTHEMA 20 0.0002
839 CYST 2 0.0002
840 MENTAL DISORDER 7 0.0002
841 HEPATIC FUNCTION ABNORMAL 6 0.0002
842 GASTRIC ULCER 3 0.0002
843 DRUG INEFFECTIVE 208 0.0002
844 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
845 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
846 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
847 SKIN BURNING SENSATION 11 0.0002
848 PRODUCT DOSE OMISSION 10 0.0002
849 VISION BLURRED 21 0.0002
850 SEPSIS 17 0.0002
851 OSTEONECROSIS 5 0.0002
852 EYE DISORDER 5 0.0002
853 WHEEZING 9 0.0002
854 INJECTION SITE HAEMORRHAGE 12 0.0002
855 COGNITIVE DISORDER 7 0.0001
856 INTENTIONAL SELF-INJURY 3 0.0001
857 TYPE 2 DIABETES MELLITUS 5 0.0001
858 FREQUENT BOWEL MOVEMENTS 4 0.0001
859 PLEURAL EFFUSION 9 0.0001
860 THROAT TIGHTNESS 4 0.0001
861 OEDEMA 8 0.0001
862 PULMONARY EMBOLISM 14 0.0001
863 ANAEMIA 28 0.0001
864 ACUTE HEPATIC FAILURE 2 0.0001
865 HAEMATURIA 5 0.0001
866 INJECTION SITE WARMTH 3 0.0001
867 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
868 ABDOMINAL DISTENSION 15 0.0001
869 FEELING COLD 4 0.0001
870 DERMATITIS 3 0.0001
871 PANCYTOPENIA 8 0.0001
872 BLOOD TEST ABNORMAL 2 0.0001
873 EATING DISORDER 3 0.0001
874 JOINT SWELLING 17 0.0001
875 PRODUCT QUALITY ISSUE 19 0.0001
876 LIVER FUNCTION TEST INCREASED 3 0.0001
877 SKIN CANCER 3 0.0001
878 LETHARGY 8 0.0001
879 VAGINAL HAEMORRHAGE 6 0.0001
880 PSORIASIS 18 0.0001
881 PRODUCT DISPENSING ERROR 3 0.0001
882 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
883 HOSPITALISATION 21 0.0001
884 CHILLS 16 0.0001
885 HAEMOGLOBIN DECREASED 14 0.0001
886 DEATH 117 0.0001
887 INCORRECT DOSE ADMINISTERED 31 0.0001
888 ACUTE MYOCARDIAL INFARCTION 4 0.0001
889 LABORATORY TEST ABNORMAL 4 0.0001
890 INJECTION SITE PRURITUS 9 0.0001
891 PULMONARY OEDEMA 6 0.0001
892 RASH PAPULAR 3 0.0001
893 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 27 0.0001
894 HEART RATE IRREGULAR 3 0.0001
895 DERMATITIS ATOPIC 7 0.0001
896 INTESTINAL OBSTRUCTION 5 0.0001
897 ILL-DEFINED DISORDER 8 0.0001
898 SEIZURE 15 0.0001
899 BASAL CELL CARCINOMA 2 0.0001
900 DRY SKIN 17 0.0001
901 PRODUCT PRESCRIBING ERROR 3 0.0001
902 RASH ERYTHEMATOUS 6 0.0001
903 PYREXIA 43 0.0001
904 DRUG INTOLERANCE 12 0.0001
905 DEVICE ISSUE 11 0.0001
906 PRODUCT USE ISSUE 23 0.0001
907 ENCEPHALOPATHY 3 0.0001
908 OSTEONECROSIS OF JAW 3 0.0001
909 INJECTION SITE PAIN 37 0.0001
910 MYOCARDIAL INFARCTION 21 0.0001
911 AGEUSIA 3 0.0001
912 COAGULOPATHY 2 0.0001
913 SKIN DISORDER 4 0.0001
914 RHABDOMYOLYSIS 5 0.0001
915 URINARY RETENTION 4 0.0001
916 ABDOMINAL PAIN LOWER 3 0.0001
917 ANGER 4 0.0001
918 CARDIAC DISORDER 11 0.0001
919 BLOOD GLUCOSE INCREASED 22 0.0001
920 GASTRIC DISORDER 4 0.0001
921 HAEMORRHAGE 12 0.0001
922 DISCOMFORT 7 0.0001
923 ECZEMA 6 0.0001
924 HYPERKALAEMIA 4 0.0001
925 PRODUCT USE IN UNAPPROVED INDICATION 28 0.0001
926 INJECTION SITE BRUISING 9 0.0001
927 CEREBROVASCULAR ACCIDENT 19 0.0001
928 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
929 MOOD ALTERED 3 0.0001
930 TREATMENT NONCOMPLIANCE 6 0.0001
931 HAEMATOCHEZIA 6 0.0001
932 BLOOD GLUCOSE ABNORMAL 2 0.0001
933 DEMENTIA 3 0.0001
934 WOUND 3 0.0001
935 DYSARTHRIA 4 0.0001
936 COLITIS 4 0.0001
937 DISEASE RECURRENCE 5 0.0001
938 ANGINA PECTORIS 3 0.0001
939 PLATELET COUNT DECREASED 11 0.0001
940 HYPOGLYCAEMIA 5 0.0001
941 NEEDLE ISSUE 3 0.0001
942 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
943 ASCITES 3 0.0001
944 COMPLICATION OF DEVICE INSERTION 2 0.0001
945 HEPATIC FAILURE 3 0.0001
946 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
947 EMOTIONAL DISORDER 3 0.0001
948 OFF LABEL USE 85 0.0001
949 SWOLLEN TONGUE 3 0.0001
950 DISEASE PROGRESSION 11 0.0001
951 ERYTHEMA 19 0.0001
952 ACNE 7 0.0001
953 LIVER DISORDER 4 0.0001
954 ADVERSE EVENT 8 0.0001
955 NEOPLASM PROGRESSION 3 0.0001
956 HEART RATE DECREASED 3 0.0001
957 DEVICE MALFUNCTION 6 0.0001
958 PRODUCT ADHESION ISSUE 3 0.0001
959 NO ADVERSE EVENT 15 0.0001
960 HYPERGLYCAEMIA 3 0.0001
961 DRUG WITHDRAWAL SYNDROME 7 0.0001
962 INJECTION SITE SWELLING 6 0.0001
963 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
964 APPLICATION SITE ERYTHEMA 2 0.0001
965 PANCREATITIS 4 0.0001
966 NEOPLASM MALIGNANT 5 0.0001
967 EXTRA DOSE ADMINISTERED 3 0.0001
968 ANAPHYLACTIC REACTION 4 0.0001
969 HYPOACUSIS 3 0.0001
970 DEVICE LEAKAGE 3 0.0001
971 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
972 ANGIOEDEMA 3 0.0001
973 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
974 SKIN IRRITATION 3 0.0001
975 THROMBOCYTOPENIA 7 0.0001
976 CARDIAC FAILURE 5 0.0001
977 TREATMENT FAILURE 5 0.0001
978 FEBRILE NEUTROPENIA 4 0.0001
979 AGGRESSION 3 0.0001
980 SKIN EXFOLIATION 5 0.0001
981 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
982 NEUTROPENIA 8 0.0001
983 BRADYCARDIA 3 0.0001
984 UNDERDOSE 4 0.0001
985 OXYGEN SATURATION DECREASED 3 0.0001
986 DRUG DEPENDENCE 8 0.0000
987 BLINDNESS 2 0.0000
988 PROSTATE CANCER 3 0.0000
989 CONVULSION 2 0.0000
990 BREAST CANCER 3 0.0000